Matthews Judith M. 4
4 · Iterum Therapeutics plc · Filed May 30, 2018
Insider Transaction Report
Form 4
Matthews Judith M.
Chief Financial Officer
Transactions
- Conversion
Ordinary Shares
2018-05-30+3,038→ 49,664 total - Purchase
Ordinary Shares
2018-05-30$13.00/sh+4,000$52,000→ 56,130 total - Conversion
Series B-1 Preferred Shares
2018-05-30−3,038→ 0 total→ Ordinary Shares (3,038 underlying) - Conversion
Series B-2 Preferred Shares
2018-05-30−2,466→ 0 total→ Ordinary Shares (2,466 underlying) - Conversion
Ordinary Shares
2018-05-30+10,980→ 46,626 total - Conversion
Ordinary Shares
2018-05-30+2,466→ 52,130 total - Conversion
Series A Preferred Shares
2018-05-30−10,980→ 0 total→ Ordinary Shares (10,980 underlying)
Footnotes (4)
- [F1]The Series A Preferred Shares automatically converted into Ordinary Shares of the Issuer on a 1-to-1 basis upon closing of the initial public offering of the Issuer.
- [F2]The Series B-1 Preferred Shares automatically converted into Ordinary Shares of the Issuer on a 1-to-1 basis upon closing of the initial public offering of the Issuer.
- [F3]The Series B-2 Preferred Shares automatically converted into Ordinary Shares of the Issuer on a 1-to-1 basis upon closing of the initial public offering of the Issuer.
- [F4]Not applicable.